4,128
Views
42
CrossRef citations to date
0
Altmetric
Research Paper

Risk and impact of herpes zoster on patients with diabetes: A population-based study, 2009–2014

, , &
Pages 2606-2611 | Received 30 May 2017, Accepted 13 Aug 2017, Published online: 22 Nov 2017

References

  • Drolet M, Brisson M, Schmader KE, Levin MJ, Johnson R, Oxman MN, Patrick D, Blanchette C, Mansi JA. The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: A prospective study. CMAJ. 2010;182(16):1731-1736. https://doi.org/10.1503/cmaj.091711. PMID:20921251
  • Arvin AM. Humoral and cellular immunity to varicella-zoster virus: An overview. J Infect Dis. 2008;197:S58-S60. https://doi.org/10.1086/522123. PMID:18419410
  • Chen N, Li Q, Yang J, Zhou M, Zhou D, He L. Antiviral treatment for preventing postherpetic neuralgia. Cochrane Database of Systematic Reviews. 2014;(2). https://doi.org/10.1002/14651858.CD006866.pub3
  • Johnson RW, Rice ASC. Postherpetic neuralgia. N Engl J Med. 2014;371(16):1526-1533. https://doi.org/10.1056/NEJMcp1403062. PMID:25317872
  • Gater A, Uhart M, McCool R, Preaud E. The humanistic, economic and societal burden of herpes zoster in europe: A critical review. BMC Public Health. 2015;15:1514-1514. https://doi.org/10.1186/s12889-015-1514-y]
  • Schmader K. Herpes zoster in older adults. Clin Infect Dis. 2001;32(10):1481-1486. https://doi.org/10.1086/320169. PMID:11317250
  • Morant-Talamante N, Diez-Domingo J, Martinez-Ubeda S, Puig-Barbera J, Aleman-Sanchez S, Perez-Breva L. Herpes zoster surveillance using electronic databases in the valencian community (spain). BMC Infect Dis. 2013;13:463.
  • Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352(22):2271-2284. https://doi.org/10.1056/NEJMoa051016. PMID:15930418
  • Harpaz R. Ortega-Sanchez IR, Seward JF, Advisory committee on immunization practices centers for D, Control and P. Prevention of herpes zoster: Recommendations of the advisory committee on immunization practices (acip). MMWR. Recomm Rep: Morb Mortal Wkly Rep. Recomm Reps / CDC. 2008;57(RR-5):1-30; quiz CE32-34.
  • Oxman MN, Levin MJ, Group SPS. Vaccination against herpes zoster and postherpetic neuralgia. J Infect Dis. 2008;197 Suppl 2:S228-236. https://doi.org/10.1086/522159]
  • Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(1):4-14. https://doi.org/10.1016/j.diabres.2009.10.007. PMID:19896746
  • Peleg AY, Weerarathna T, McCarthy JS, Davis TME. Common infections in diabetes: Pathogenesis, management and relationship to glycaemic control. Diabetes Metab Res Rev. 2007;23(1):3-13. https://doi.org/10.1002/dmrr.682. PMID:16960917
  • Geerlings SE, Hoepelman AIM. Immune dysfunction in patients with diabetes mellitus (dm). FEMS Immunol Med Microbiol. 1999;26(3-4):259-265.
  • Guignard AP, Greenberg M, Lu C, Rosillon D, Vannappagari V. Risk of herpes zoster among diabetics: A matched cohort study in a us insurance claim database before introduction of vaccination, 1997–2006. Infection. 2014;42(4):729-735.
  • Suaya JA, Chen S-Y, Li Q, Burstin SJ, Levin MJ. Incidence of herpes zoster and persistent post-zoster pain in adults with or without diabetes in the united states. Open Forum Infect Dis. 2014;1(2):ofu049.[https://doi.org/10.1093/ofid/ofu049. PMID:25734121
  • Aldaz P, Diaz JA, Loayssa JR, Dronda MJ, Oscariz M, Castilla J. Herpes zoster incidence in diabetic patients. An Sist Sanit Navar. 2013;36(1):57-62. https://doi.org/10.4321/S1137-66272013000100006. PMID:23648493
  • Heymann AD, Chodick G, Karpati T, Kamer L, Kremer E, Green MS, Kokia E, Shalev V. Diabetes as a risk factor for herpes zoster infection: Results of a population-based study in israel. Infection. 2008;36(3):226-230. https://doi.org/10.1007/s15010-007-6347-x. PMID:18454342
  • Forbes HJ, Bhaskaran K, Thomas SL, Smeeth L, Clayton T, Langan SM. Quantification of risk factors for herpes zoster: Population based case-control study. BMJ. 2014;348:g2911.[https://doi.org/10.1136/bmj.g2911. PMID:25134101
  • Ragozzino MW, Melton LJ, Kurland LT. Herpes-zoster and diabetes-mellitus – an epidemiological investigation. J Chronic Dis. 1983;36(7):501-505. https://doi.org/10.1016/0021-9681(83)90127-3. PMID:6874881
  • Donahue JG, Choo PW, Manson JE, Platt R. The incidence of herpes-zoster. Arch Intern Med. 1995;155(15):1605-1609.
  • McDonald JR, Zeringue AL, Caplan L, Ranganathan P, Xian H, Burroughs TE, Fraser VJ, Cunningham F, Eisen SA. Herpes zoster risk factors in a national cohort of veterans with rheumatoid arthritis. Clin Infect Dis. 2009;48(10):1364-1371. https://doi.org/10.1086/598331. PMID:19368499
  • Lasserre A, Blaizeau F, Gorwood P, Bloch K, Chauvin P, Liard F, Blanchon T, Hanslik T. Herpes zoster: Family history and psychological stress-case-control study. J Clin Virol. 2012;55(2):153-157. https://doi.org/10.1016/j.jcv.2012.06.020. PMID:22824229
  • Okamoto S, Hata A, Sadaoka K, Yamanishi K, Mori Y. Comparison of varicella-zoster virus-specific immunity of patients with diabetes mellitus and healthy individuals. J Infect Dis. 2009;200(10):1606-1610. https://doi.org/10.1086/644646. PMID:19821719
  • Instituto nacional de estadística. Cifras oficiales de población resultantes de la revisión del padrón municipal a 1 de enero de 2014. 2014 . [accessed]. http://www.ine.es/dynt3/inebase/es/index.html?padre=517&dh=1.
  • Indra sistemas sa: Proyecto abucasis conselleria sanitat valencia. 2012. [ accessed]. http://www.indracompany.com/sectores/sanidad/proyectos/179/proyecto-abucasis-conselleria-de-sanitat-valencia.
  • Munoz-Quiles C, Lopez-Lacort M, Ubeda-Sansano I, Aleman-Sanchez S, Perez-Vilar S, Puig-Barbera J, Diez-Domingo J. Population-based analysis of bronchiolitis epidemiology in valencia, spain. Pediatr Infect Dis J. 2016;35(3):275-280. https://doi.org/10.1097/INF.0000000000000993. PMID:26658376
  • Weitzman D, Shavit O, Stein M, Cohen R, Chodick G, Shalev V. A population based study of the epidemiology of herpes zoster and its complications. J Infect. 2013;67(5):463-469. https://doi.org/10.1016/j.jinf.2013.06.016. PMID:23872209
  • Chen H-H, Lin IC, Chen H-J, Yeh S-Y, Kao C-H. Association of herpes zoster and type 1 diabetes mellitus. Plos One. 2016;11(5):e0155175. https://doi:10.1371/journal.pone.0155175
  • Li Q, Ali MA, Cohen JI. Insulin degrading enzyme is a cellular receptor mediating varicella-zoster virus infection and cell-to-cell spread. Cell. 2006;127(2):305-316. https://doi.org/10.1016/j.cell.2006.08.046. PMID:17055432
  • Cebrian-Cuenca AM, Diez-Domingo J, San-Martin-Rodriguez M, Puig-Barbera J, Navarro-Perez J, Herpes Zoster Res Grp V. Epidemiology and cost of herpes zoster and postherpetic neuralgia among patients treated in primary care centres in the valencian community of spain. BMC Infect Dis. 2011;11:302. https://doi.org/10.1186/1471-2334-11-302
  • Luis Lopez-Belmonte J, Cisterna R, Gil de Miguel A, Guilmet C, Bianic F, Uhart M. The use of zostavax in spain: The economic case for vaccination of individuals aged 50 years and older. J Med Econ. 2016;19(6):576-586. https://doi.org/10.3111/13696998.2016.1146726. PMID:26808422
  • Pérez-Vilar S, Díez-Domingo J, Puig-Barberá J, Gil-Prieto R, Romio S. Intussusception following rotavirus vaccination in the valencia region, spain. Hum Vaccin Immunother. 2015;11(7):1848–52. https://doi.org/10.1080/21645515.2015.1049787. PMID:26083707